Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant

Nasal administration of influenza vaccine has the potential to facilitate influenza control and prevention. However, when administered intranasally (i.n.), commercially available inactivated vaccines only generate systemic and mucosal immune responses if strong adjuvants are used, which are often as...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Saluja, Vinay, Amorij, Jean P., van Roosmalen, Maarten L., Leenhouts, Kees, Huckriede, Anke, Hinrichs, Wouter L. J., Frijlink, Henderik W.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer US 2010
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2844513/
https://ncbi.nlm.nih.gov/pubmed/20058113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-009-9168-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak